prr in trading halt, page-56

Nice day on the market, but I do not think it was "insiders" buying in the past few days. There have been numerous people saying PRR had technically bottomed out, and combined with the anticipated release of good news, created a catalyst for buying.
Lets also not forget a certain stock tipping entity rated PRR a buy...and we have all seen the reaction that can have!

On another note, the below is an excerpt from an email I received from MR on the 25/8/2011 after questioning him about administering CVac:

"What is stock standard in the biotech industry is to apply for a label and then run clinical trials after marketing approval in US and EU for a “label expansion” this can be done on anecdotal evidence typically from oncologists using the product outside of label. In the US for instance it is ok for doctors to use a drug off-label and is very common, however, it is illegal in the US for a company to market a drug off-label. The remedy to increase the label is to run other studies."